Integrated Management of Kidney Failure: Pathophysiological Pathways, Renal-Replacement Innovations, and Paramedical Competency: A PRISMA Narrative Review

Abstract

Background and hypothesis: Chronic kidney disease (CKD) and acute kidney injury (AKI) share a pathobiological cascade—hyperfiltration, inflammation, oxidative stress, and fibrosis—that accelerates nephron loss and amplifies cardiovascular risk. Renal‑replacement innovations (e.g., high‑volume online hemodiafiltration, ol‑HDF) and workforce interventions (simulation-enhanced training) are proposed levers to improve outcomes, but their effectiveness depends on infrastructure and process fidelity. Hypothesis: In adults with advanced CKD/end-stage kidney disease, programs that deliver high‑volume of‑HDF (post-dilution convective volume ≥20 L/session) together with standardised, simulation-based paramedical training will achieve ≥15% relative reduction in cardiovascular mortality and ≥25% reduction in dialysis-related incidents versus high-flux hemodialysis without such training. Aim: The review aims to explore pathophysiological pathways, renal-replacement innovations, and paramedical competency for integrated management of kidney failure. Methods: We conducted a PRISMA-guided narrative review of a pre-compiled doctoral corpus (2022–March 2024). Records were de-duplicated, dual-screened (titles/abstracts, then full text), and included if they addressed pathophysiology/biomarkers, extracorporeal technologies, or paramedical training/quality. Data were extracted in duplicate using a piloted form; study-level appraisal used RoB 2/ROBINS‑I/STROBE/CONSORT/AMSTAR‑2 as appropriate. Given heterogeneity, we performed thematic (inductive–deductive) synthesis rather than meta-analysis. Results: From 230 records, 28 duplicates were removed; 202 were screened, and 172 included. Evidence converged on a hyperfiltration→inflammation/oxidative stress→fibrosis pathway driving CKD progression; albuminuria, β₂‑microglobulin, and inflammatory cytokines were consistent risk markers. High‑volume ol‑HDF improved middle‑molecule removal and was associated with 10–17% lower cardiovascular mortality versus high‑flux hemodialysis in several trials/registries, though some randomised studies were underpowered. Hybrid ICU modalities (SLED/SLED‑f) were generally non-inferior to continuous RRT for survival with logistical advantages. Synthetic high-flux membranes (polysulfone/polyethersulfone) reduced complement activation versus cellulose. Continuing‑education programs that applied adult‑learning principles and high‑fidelity simulation reduced dialysis-related incidents by ~20–30% and improved maintenance and alarm‑response practices. Conclusion: An integrated strategy that targets upstream biology, deploys ol‑HDF where infrastructure allows, and professionalises dialysis teams via simulation-based education is most likely to improve survival, safety, and patient experience. Priorities include validating early multimarker panels, adequately powered trials testing target convective volumes, rigorous implementation/cost-effectiveness evaluations, and accredited competency frameworks to standardise practice across centres. Future work should validate early multimarker panels for risk stratifiedrisk-stratified screening and therapeutic monitoring; test target convection volumes and patient-centred endpoints in sufficiently powered trials; and conduct implementation and cost effectivenesscost-effectiveness studies of olHDF and hybrid ICU modalities in resource-limited systems.